CHI3L1 and mild neurocognitive disorder: Based on these premises, we decided to carry out a pilot study in order to compare the levels of the CHI3L1 in the plasma samples gathered during the first visits to our center, which were obtained from MND patients, MND mimics, and healthy controls (HCs).